Analysis of Coronary Stent in US
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : May, 2013| No. of Pages : 45
1. Analyst View
2. Research Methodology
3. Healthcare Expenditure - Cardiovascular Diseases
3.1 High Healthcare Expenditure in US - The Issue
3.2 Reasons for High Expenditure related to Health
3.3 Burden of Chronic Diseases on Healthcare Expenditure
4. US Coronary Stent Market Analysis to 2017
5. Technology Assessment: 2012 FDA Approved Stents
5.1 Zilver PTX Stent
5.2 S.M.A.R.T. CONTROL Stent System
5.3 Medtronic Valiant Thoracic Stent Graft
5.4 OVATION Abdominal Stent Graft
5.5 Omnilink Elite Stent System
5.6 Relay Thoracic Stent-Graft
5.7 PROMUS Element Stent System
5.8 Presillion plus Stent
5.9 Epic Vascular Stent System
5.10 Zenith Fenestrated AAA Endovascular Graft
5.11 EverFlex Self-Expanding Peripheral Stent System
5.12 TAXUS Liberté Stent System
5.13 TAXUS Express2 Stent System
5.14 ION Coronary Stent System
5.15 Resolute MicroTrac and Resolute Integrity Coronary Stent System
5.16 Absolute Pro Vascular Stent System
5.17 GORE TAG Stent Graft
6. Competitive Analysis
6.1 Covidien
6.1.1 Business Description
6.1.2 Company Presence in Stent Business
6.2 Medtronic
6.2.1 Business Description
6.2.2 Company Presence in Stent Business
6.3 Boston Scientific
6.3.1 Business Description
6.3.2 Company Presence in Stent Business
6.4 W.L. Gore & Associates
6.4.1 Business Description
6.4.2 Company Presence in Stent Business
6.5 Cordis Corporation
6.5.1 Business Description
6.5.2 Company Presence in Stent Business